Nanomedical Diagnostics Announces Office Move to Accommodate Company Growth To support upcoming product launches and expanding headcount, the San Diego-based company will triple its space in a new facility.

SAN DIEGO, Calif.– Nanomedical Diagnostics, leading producer of graphene biosensors for pharmaceutical and biotherapeutics research, announces a headquarters relocation to 9640 Towne Centre Drive, Suite 100, effectively tripling its space from 5,200 to 16,500 square feet.

“This past year has seen exponential growth, both domestically and internationally, for the sales of our drug discovery platforms. We’re in the great position of having to move to a new space to accommodate expanded production and R&D,” says Nanomedical Diagnostics CEO, Ross Bundy. “Our new building enables better operational efficiencies for our production lines and brings departments that were formerly separated in different locations together under one roof. This allows for better collaboration and innovation as we launch new products and grow our staff.”

The company’s move places it in the heart of the biotech sector in San Diego, providing closer proximity to key customers, as well as additional amenities such as large meeting rooms, a reception area, and exercise facilities. The versatile building is equipped to support a large R&D laboratory, shipping and delivery staging, expanded production capacity, and additional office staff.

“2019 promises to be an exciting year for the company,” continues Mr. Bundy. “We’re launching a new high-throughput drug discovery product early in the year and are in the process of hiring in all departments to support increased sales. We are also expanding our line of industrial OEM graphene sensors for use by partners in diverse industries and are thrilled to find a space that can accommodate our projected growth over the next few years.”

Nanomedical Diagnostics’ official move date is December 10, 2018.

About Nanomedical Diagnostics

Nanomedical Diagnostics (“Nanomed”) is a life science company based in San Diego, CA. As the world’s leading manufacturer and developer of next-generation graphene biosensors, Nanomed’s mission is to transform the healthcare industry with innovative new products that enable cutting-edge life science research, drug discovery applications, and portable diagnostic and health monitoring platforms.